Cargando…
Drug-Induced Kounis Syndrome: Latest Novelties
Kounis syndrome (KS) is defined by an acute coronary syndrome associated with hypersensitivity reactions, an under-diagnosed life-threatening medical emergency. Although multiple causes have been described, drugs constitute the most frequent cause. The purpose of this review is to update knowledge a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227395/ https://www.ncbi.nlm.nih.gov/pubmed/37361641 http://dx.doi.org/10.1007/s40521-023-00342-9 |
_version_ | 1785050762008592384 |
---|---|
author | Ollo-Morales, Paula Gutierrez-Niso, Marta De-la-Viuda-Camino, Elena Ruiz-de-Galarreta-Beristain, Marina Osaba-Ruiz-de-Alegria, Ixone Martel-Martin, Carlota |
author_facet | Ollo-Morales, Paula Gutierrez-Niso, Marta De-la-Viuda-Camino, Elena Ruiz-de-Galarreta-Beristain, Marina Osaba-Ruiz-de-Alegria, Ixone Martel-Martin, Carlota |
author_sort | Ollo-Morales, Paula |
collection | PubMed |
description | Kounis syndrome (KS) is defined by an acute coronary syndrome associated with hypersensitivity reactions, an under-diagnosed life-threatening medical emergency. Although multiple causes have been described, drugs constitute the most frequent cause. The purpose of this review is to update knowledge about drug-induced KS, to give guidelines on the correct diagnosis and treatment. This article reviews the literature on drug-induced KS from the last 5 years. Antibiotics and NSAIDs are the most frequently implicated drugs. In addition, data on pathophysiology, clinical presentation, diagnosis, and management are reviewed in detail. Highlight that there is a great deal of variability in the diagnosis and especially in the treatment of KS. This review provides a valuable selection of practical resources for all stakeholders to support effective care for KS, from a cardiologic and allergologic point of view. Future research should focus on developing validated, evidence-based, and patient-centered tools to improve the management of KS. |
format | Online Article Text |
id | pubmed-10227395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-102273952023-06-01 Drug-Induced Kounis Syndrome: Latest Novelties Ollo-Morales, Paula Gutierrez-Niso, Marta De-la-Viuda-Camino, Elena Ruiz-de-Galarreta-Beristain, Marina Osaba-Ruiz-de-Alegria, Ixone Martel-Martin, Carlota Curr Treat Options Allergy Article Kounis syndrome (KS) is defined by an acute coronary syndrome associated with hypersensitivity reactions, an under-diagnosed life-threatening medical emergency. Although multiple causes have been described, drugs constitute the most frequent cause. The purpose of this review is to update knowledge about drug-induced KS, to give guidelines on the correct diagnosis and treatment. This article reviews the literature on drug-induced KS from the last 5 years. Antibiotics and NSAIDs are the most frequently implicated drugs. In addition, data on pathophysiology, clinical presentation, diagnosis, and management are reviewed in detail. Highlight that there is a great deal of variability in the diagnosis and especially in the treatment of KS. This review provides a valuable selection of practical resources for all stakeholders to support effective care for KS, from a cardiologic and allergologic point of view. Future research should focus on developing validated, evidence-based, and patient-centered tools to improve the management of KS. Springer International Publishing 2023-05-30 /pmc/articles/PMC10227395/ /pubmed/37361641 http://dx.doi.org/10.1007/s40521-023-00342-9 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Ollo-Morales, Paula Gutierrez-Niso, Marta De-la-Viuda-Camino, Elena Ruiz-de-Galarreta-Beristain, Marina Osaba-Ruiz-de-Alegria, Ixone Martel-Martin, Carlota Drug-Induced Kounis Syndrome: Latest Novelties |
title | Drug-Induced Kounis Syndrome: Latest Novelties |
title_full | Drug-Induced Kounis Syndrome: Latest Novelties |
title_fullStr | Drug-Induced Kounis Syndrome: Latest Novelties |
title_full_unstemmed | Drug-Induced Kounis Syndrome: Latest Novelties |
title_short | Drug-Induced Kounis Syndrome: Latest Novelties |
title_sort | drug-induced kounis syndrome: latest novelties |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227395/ https://www.ncbi.nlm.nih.gov/pubmed/37361641 http://dx.doi.org/10.1007/s40521-023-00342-9 |
work_keys_str_mv | AT ollomoralespaula druginducedkounissyndromelatestnovelties AT gutierreznisomarta druginducedkounissyndromelatestnovelties AT delaviudacaminoelena druginducedkounissyndromelatestnovelties AT ruizdegalarretaberistainmarina druginducedkounissyndromelatestnovelties AT osabaruizdealegriaixone druginducedkounissyndromelatestnovelties AT martelmartincarlota druginducedkounissyndromelatestnovelties |